Products for Research Use Only
RegisterLogin

Cilgavimab

CAT: 0804-HY-P99604-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99604-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab. Cilgavimab shows protective action on mouse models of SARS-CoV-2 infection[1].
CAS Number
2420563-99-9
Product Name Alternative
AZD-1061; COV2-2130
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cilgavimab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Cilgavimab]
Molecular Weight
(148.82 kDa)
References & Citations
[1]Levin MJ, et al; PROVENT Study Group. Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19. N Engl J Med. 2022 Jun 9;386 (23) :2188-2200. |[2]Zost SJ, et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020 Aug;584 (7821) :443-449.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
591750Cilgavimab
GTR18337771-01Cilgavimab Antibody
E40YR1623Cilgavimab (AZD1061)
MBS1564015-01Research Grade Cilgavimab
E55B0640Cilgavimab (Reference antibody)
ICH5438-1mgCilgavimab Biosimilar - Research Grade
GTR18780482-01(Cilgavimab) Biosimilar Reference Antibody
047622Spike RBD (Cilgavimab) discontinued
21-893Cilgavimab - Research Grade Biosimilar
GTR18698013-01Cilgavimab Human Monoclonal Antibody

Popular Products